NCT02882698

Brief Summary

The game Marble Maze Classic® will be used, in which the participants have to move the mobile phone to conduct a virtual marble through a maze design. The investigators will evaluate 100 individuals (50 with Down Syndrome-DS and 50 with typical development-TD) and divide both with DS and TD into group 1 and 2, where each group consists of 25 participants, with group 2 using a maze design totally opposite to group 1.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 30, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 11, 2017

Status Verified

April 1, 2017

Enrollment Period

2 months

First QC Date

August 18, 2016

Last Update Submit

April 8, 2017

Conditions

Keywords

Down syndromemotor skillsphysiotherapymobile telephoneexposure to virtual reality therapy

Outcome Measures

Primary Outcomes (1)

  • Improvement of performance

    that individuals with DS would be able to adapt to the virtual task using the mobile phone and improve performance with practice in acquisition, as well as maintain the performance in transfer tasks, namely, to change the maze.

    Up to 3 months

Study Arms (4)

Down Syndrome Group 1

EXPERIMENTAL

Acquisition and retention phase on maze A, transfer on maze B and C.

Behavioral: Down Syndrome Group 1

Down Syndrome Group 2

EXPERIMENTAL

Acquisition and retention phase on maze C, transfer on maze A and B.

Behavioral: Down Syndrome Group 2

Typical Development Group 1

ACTIVE COMPARATOR

Control group. Acquisition and retention phase on maze A, transfer on maze B and C.

Behavioral: Typical Development Group 1

Typical Development Group 2

ACTIVE COMPARATOR

Control group. Acquisition and retention phase on maze C, transfer on maze A and B.

Behavioral: Typical Development Group 2

Interventions

Acquisition and retention phase on maze A, transfer on maze B and C.

Down Syndrome Group 1

Acquisition and retention phase on maze C, transfer on maze A and B.

Down Syndrome Group 2

Control group. Acquisition and retention phase on maze A, transfer on maze B and C.

Typical Development Group 1

Control group. Acquisition and retention phase on maze C, transfer on maze A and B.

Typical Development Group 2

Eligibility Criteria

Age11 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • diagnosis of DS;
  • ability to perform a gripping movement to hold the mobile phone with one of the hands.

You may not qualify if:

  • presence of comorbidities such as autism or other associated genetic alterations;
  • functional disability that impedes the execution of the task or failure of task comprehension after five attempts carried out during the familiarization phase.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Associacao de Pais e Amigos dos Excepcionais de Amparo (APAE)

Amparo, São Paulo, 13905-010, Brazil

Location

MeSH Terms

Conditions

Down Syndrome

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Study Officials

  • Carlos BM Monteiro, Ph.D.

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 18, 2016

First Posted

August 30, 2016

Study Start

September 1, 2016

Primary Completion

November 1, 2016

Study Completion

December 1, 2016

Last Updated

April 11, 2017

Record last verified: 2017-04

Locations